Evidence map›Paper›PMID 32555455›Full record

ArticleNature2020

A metabolic pathway for bile acid dehydroxylation by the gut microbiome.

Masanori Funabashi, Tyler L Grove, Min Wang, Yug Varma, Molly E McFadden, Laura C Brown, Chunjun Guo, Steven Higginbottom, Steven C Almo, Michael A Fischbach

Open access · greenAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 365 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
365citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

365 citing papers in PubMed, 2 syntheses or guidelines pooled it, 518 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Expanding bile acid diversityNatural product reports · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

305 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Masanori Funabashi *Department of Bioengineering and ChEM-H, Stanford University, Stanford, CA, USA.
Tyler L Grove *Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.
Min WangDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA, USA.
Yug VarmaDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA, USA.
Molly E McFaddenDepartment of Chemistry, Indiana University, Bloomington, IN, USA.
Laura C BrownDepartment of Chemistry, Indiana University, Bloomington, IN, USA.
Chunjun GuoDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA, USA.
Steven HigginbottomDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Steven C AlmoDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA. steve.almo@einstein.yu.edu.
Michael A FischbachDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA, USA. fischbach@fischbachgroup.org.
Stanford University · USAlbert Einstein College of Medicine · USIndiana University Bloomington · USChan Zuckerberg Initiative (United States) · US

Funding

Core H: MicrobiologyU54GM093342 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CRONAN, JOHN E. · 2010 to 2015
$34.6M
The NYSGRC: A Large Scale Center for PSI:BiologyU54GM094662 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SEIDEL, RONALD D · 2010 to 2014
$32.6M
Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic diseaseP01HL147823 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MICHAEL ANDREW FISCHBACH · 2019 to 2026
$17.0M
Protein/Structure CoreP01GM118303 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI JACOBSON, MATTHEW P · 2016 to 2020
$11.4M
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced MetabolitesR01DK101674 · NIDDK · STANFORD UNIVERSITY · PI FISCHBACH, MICHAEL ANDREW, MEYER, TIMOTHY W · 2014 to 2024
$6.5M
A complete map of the top 100 molecules from the gut microbiomeDP1DK113598 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2020
$5.5M
An integrative and generalizable approach to modulate microbiota small molecules in the hostDP2HD101401 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI GUO, CHUN-JUN · 2019 to 2019
$2.5M
Identification and characterization of natural products from the human microbiotaR01DK110174 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2019
$1.4M
Howard Hughes Medical InstituteNHLBI NIH HHS P01 HL147823NICHD NIH HHS DP2 HD101401NIDDK NIH HHS DP1 DK113598NIDDK NIH HHS R01 DK101674NIDDK NIH HHS R01 DK110174NIGMS NIH HHS P01 GM118303NIGMS NIH HHS U54 GM093342NIGMS NIH HHS U54 GM094662
6 · The paper itself

Abstract

The gut microbiota synthesize hundreds of molecules, many of which influence host physiology. Among the most abundant metabolites are the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA), which accumulate at concentrations of around 500 μM and are known to block the growth of Clostridium difficile

Indexed as

AnimalsBile Acids and SaltsClostridiumDeoxycholic AcidGastrointestinal MicrobiomeHydroxylationLithocholic AcidMaleMetabolic EngineeringMetabolic Networks and PathwaysMiceOperonSymbiosisBile Acids and SaltsDeoxycholic AcidLithocholic Acid

Identifiers

PMID32555455
PMCPMC7319900
OpenAlexW3036012425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.